NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/22/2026
Back to search
Official data from USPTO
PELAGO BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/10/2026
Classification
Registered
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
12/03/2018
Registration date
08/27/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2026
Last transaction
02/10/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SE
Examiner
SHOSHO II, ERNEST
Current location
Historical data usage
Mark description
The mark consists of the words "PELAGO BIOSCIENCE" in dark blue stylized font. Next to the wording is a dark blue design of a circular like shape.
Holders and representatives
Holders
Pelago Bioscience AB
Representatives
Garth M. Dahlen Mendelsohn Dunleavy, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical compositions and materials for use in science; biochemicals for in vitro and in vivo scientific use; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; tagged antibodies for laboratory use; tagged antibodies for scientific use; polymers for use in the analysis of proteins; reagents for scientific purposes; chemicals compositions for scientific use in the preparation of culture media; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; testing reagents for scientific use; universal reagents for automated test systems for laboratory use; universal reagents for automated test systems for scientific use; chemical substances for scientific purposes; enzymes for scientific purposes; enzymes for scientific and research purposes in detecting proteins; proteins for scientific and research purposes for detecting antibodies; proteins for use in science; protein for scientific and research purposes; chemical substances for impregnation into membranes to separate proteins from liquids for scientific and research purposes
Class 5
Enzymes for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic testing materials for medical use; diagnostic reagents for medical use; medical diagnostic test strips; chemical reagents for medical or veterinary purposes; chemical test reagents for medical use; chemical test reagents for veterinary use; reagents for analytical purposes for medical use; reagents for use in analysis for medical use; reagents for in-vitro laboratory use for medical purposes; reagents and media for medical and veterinary diagnostic purposes
Class 42
Laboratory scientific and research services in the fields of chemistry and biology; research and development services in the scientific and medical field; laboratory testing; scientific laboratory services; testing of pharmaceuticals; analysis of human tissues for medical research; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; medical research; medical laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; scientific research and development in the scientific and medical field; biochemical research and development; biochemical analysis; biochemistry research services; biological analysis; biomedical research services; chemical research and analysis services
Publications
History of USPTO decisions and trademark events.
27 publications found
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
01/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/12/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
ES71
TEAS SECTION 71 RECEIVED
09/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/17/2019
FIMP
FINAL DISPOSITION PROCESSED
12/17/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/27/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2019
PUBO
PUBLISHED FOR OPPOSITION
06/11/2019
NPUB
NOTICE OF PUBLICATION
05/22/2019
ALIE
ASSIGNED TO LIE
05/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/24/2019
RFNT
REFUSAL PROCESSED BY IB
04/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2019
RFRR
REFUSAL PROCESSED BY MPU
03/28/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/20/2019
CNRT
NON-FINAL ACTION WRITTEN
03/19/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/19/2019
DOCK
ASSIGNED TO EXAMINER
03/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/15/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2019
Continuous trademark protection
Get notified about every new filing that threatens PELAGO BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.